DUBLIN--(BUSINESS WIRE)--The "Global Antibiotics Market - Growth, Trends and Forecasts 2017 - 2022" report has been added to Research and Markets' offering.
In recent years, a steady increase in the microbial resistance to antibiotics has become a major threat to global public health. Experts have been warned of the return of pre-antibiotic era, due to an increasing resistance to most widely used treatments and a few new antibiotics in development. Antibiotic resistance accounts for 50,000 deaths per year in the US and Europe alone. Routine surgeries and minor infections might become life threatening if novel antibiotics are not developed.
In spite of microbial resistance being a major concern, very few companies are actively involved in research. Mergers between pharmaceutical companies have also reduced the number and diversity of the research teams. However, developed countries with well-funded health care systems are taking preventive measures. Development of novel antibiotics against multi-drug resistant organisms may help the antibiotics market growth.
The emergence of anti-MRSA/VRE drugs, development of generic drugs, and vulnerable aging population are the major drivers for the growth of antibiotics market. Market restraints include antibiotic resistance, fewer companies involved in active research, and the time taken for regulatory approval.
Companies Mentioned:
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Pfizer
- Astrazeneca
- Bayer Healthcare AG
- Novartis
- Sanofi
- Abbott Laboratories
- Roche
Key Topics Covered:
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Characterization
6. Industry Analysis
7. Competitive Landscape
8. Company Profiles
9. Future Outlook
For more information about this report visit https://www.researchandmarkets.com/research/95xs7g/global
